The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses

Cytokine and Growth Factor Reviews

Volumn 29, Issue , 2016, Pages 71-81

  Blaszczyk, Katarzyna ^a   Nowicka, Hanna ^a   Kostyrko, Kaja ^a   Antonczyk, Aleksandra ^a   Wesoly, Joanna ^a   Bluyssen, Hans A R ^a  

^a ADAM MICKIEWICZ UNIVERSITY   (Poland)

Author keywords

Alternative interferon response pathway; Cytokines interferon; Host pathogen interactions; ISGF3; Signal transduction; STAT2 transcription factor; STAT2 IRF9

Indexed keywords

INTERFERON; INTERFERON REGULATORY FACTOR 9; INTERFERON STIMULATED GENE FACTOR 3; STAT1 PROTEIN; STAT2 PROTEIN; IRF9 PROTEIN, HUMAN; STAT2 PROTEIN, HUMAN;

COMPLEX FORMATION; GENE; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; INFECTION RESISTANCE; INTERFERON PRODUCTION; INTERFERON STIMULATED GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SHORT SURVEY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TRANSCRIPTION REGULATION; VIRUS IMMUNITY; VIRUS INFECTION; ANIMAL; DNA RESPONSIVE ELEMENT; GENETIC TRANSCRIPTION; IMMUNOLOGY;

ANIMALS; HUMANS; INTERFERON TYPE I; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; STAT2 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; VIRUS DISEASES;

EID: 84971232255     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2016.02.010     Document Type: Short Survey

References (88)

1. Fensterl V., Sen G.C. Interferons and viral infections. Biofactors 2009, 35:14-20.
2. Schindler C., Levy D.E., Decker T. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 2007, 282:20059-20063.
3. Prokunina-Olsson L., Muchmore B., Tang W., Pfeiffer R.M., Park H., Dickensheets H., et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat. Genet. 2013, 45:164-171.
4. Liu Y.J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 2005, 23:275-306.
5. Koyama S., Ishii K.J., Coban C., Akira S. Innate immune response to viral infection. Cytokine 2008, 43:336-341.
6. Pichlmair A., Reis e Sousa C. Innate recognition of viruses. Immunity 2007, 27:370-383.
7. Miyamoto M., Fujita T., Kimura Y., Maruyama M., Harada H., Sudo Y., et al. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell 1988, 54:903-913.
8. Lazear H.M., Lancaster A., Wilkins C., Suthar M.S., Huang A., Vick S.C., et al. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog. 2013, 9:e1003118.
9. Li P., Wong J.J., Sum C., Sin W.X., Ng K.Q., Koh M.B., et al. IRF8 and IRF3 cooperatively regulate rapid interferon-beta induction in human blood monocytes. Blood 2011, 117:2847-2854.
10. Honda K., Takaoka A., Taniguchi T. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 2006, 25:349-360.
11. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
12. Kisseleva T., Bhattacharya S., Braunstein J., Schindler C.W. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 2002, 285:1-24.
13. Cohen B., Novick D., Barak S., Rubinstein M. Ligand-induced association of the type I interferon receptor components. Mol. Cell. Biol. 1995, 15:4208-4214.
14. Piehler J., Thomas C., Garcia K.C., Schreiber G. Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation. Immunol. Rev. 2012, 250:317-334.
15. Luker K.E., Smith M.C., Luker G.D., Gammon S.T., Piwnica-Worms H., Piwnica-Worms D. Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:12288-12293.
16. Neculai D., Neculai A.M., Verrier S., Straub K., Klumpp K., Pfitzner E., et al. Structure of the unphosphorylated STAT5a dimer. J. Biol. Chem. 2005, 280:40782-40787.
17. Shuai K., Horvath C.M., Huang L.H., Qureshi S.A., Cowburn D., Darnell J.E. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 1994, 76:821-828.
18. Levy D.E., Darnell J.E. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 2002, 3:651-662.
19. Haque S.J., Williams B.R. Identification and characterization of an interferon (IFN)-stimulated response element-IFN-stimulated gene factor 3-independent signaling pathway for IFN-alpha. J. Biol. Chem. 1994, 269:19523-19529.
20. Horvath C.M., Wen Z., Darnell J.E. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 1995, 9:984-994.
21. Xu X., Sun Y.L., Hoey T. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 1996, 273:794-797.
22. Brierley M.M., Fish E.N. Functional relevance of the conserved DNA-binding domain of STAT2. J. Biol. Chem. 2005, 280:13029-13036.
23. Ghislain J.J., Wong T., Nguyen M., Fish E.N. The interferon-inducible Stat2:Stat1 heterodimer preferentially binds in vitro to a consensus element found in the promoters of a subset of interferon-stimulated genes. J. Interferon Cytokine Res. 2001, 21:379-388.
24. Gupta S., Jiang M., Pernis A.B. IFN-alpha activates Stat6 and leads to the formation of Stat2:Stat6 complexes in B cells. J. Immunol. 1999, 163:3834-3841.
25. Li X., Leung S., Qureshi S., Darnell J.E. Stark GR. Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha. J. Biol. Chem. 1996, 271:5790-5794.
26. Blaszczyk K., Olejnik A., Nowicka H., Ozgyin L., Chen Y.L., Chmielewski S., et al. STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1. Biochem. J. 2015, 466:511-524.
27. Abdul-Sater A.A., Majoros A., Plumlee C.R., Perry S., Gu A.D., Lee C., et al. Different STAT transcription complexes drive early and delayed responses to type I IFNs. J. Immunol. 2015, 195:210-216.
28. Paulson M., Pisharody S., Pan L., Guadagno S., Mui A.L., Levy D.E. Stat protein transactivation domains recruit p300/CBP through widely divergent sequences. J. Biol. Chem. 1999, 274:25343-25349.
29. Park C., Lecomte M.J., Schindler C. Murine Stat2 is uncharacteristically divergent. Nucleic Acids Res. 1999, 27:4191-4199.
30. Farrar J.D., Smith J.D., Murphy T.L., Leung S., Stark G.R., Murphy K.M. Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2. Nat. Immunol. 2000, 1:65-69.
31. Chen L.S., Wei P.C., Liu T., Kao C.H., Pai L.M., Lee C.K. STAT2 hypomorphic mutant mice display impaired dendritic cell development and antiviral response. J. Biomed. Sci. 2009, 16:22.
32. Sugiyama T., Nishio Y., Kishimoto T., Akira S. Identification of alternative splicing form of Stat2. FEBS Lett. 1996, 381:191-194.
33. Tamura T., Yanai H., Savitsky D., Taniguchi T. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 2008, 26:535-584.
34. Banninger G., Reich N.C. STAT2 nuclear trafficking. J. Biol. Chem. 2004, 279:39199-39206.
35. Seegert D., Strehlow I., Klose B., Levy D.E., Schindler C., Decker T. A novel interferon-alpha-regulated, DNA-binding protein participates in the regulation of the IFP53/tryptophanyl-tRNA synthetase gene. J. Biol. Chem. 1994, 269:8590-8595.
36. Melen K., Kinnunen L., Julkunen I. Arginine/lysine-rich structural element is involved in interferon-induced nuclear import of STATs. J. Biol. Chem. 2001, 276:16447-16455.
37. Fagerlund R., Melen K., Kinnunen L., Julkunen I. Arginine/lysine-rich nuclear localization signals mediate interactions between dimeric STATs and importin alpha 5. J. Biol. Chem. 2002, 277:30072-30078.
38. Mertens C., Zhong M., Krishnaraj R., Zou W., Chen X., Darnell J.E. Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain. Genes Dev. 2006, 20:3372-3381.
39. Martinez-Moczygemba M., Gutch M.J., French D.L., Reich N.C. Distinct STAT structure promotes interaction of STAT2 with the p48 subunit of the interferon-alpha-stimulated transcription factor ISGF3. J. Biol. Chem. 1997, 272:20070-20076.
40. Li X., Leung S., Kerr I.M., Stark G.R. Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling. Mol. Cell. Biol. 1997, 17:2048-2056.
41. Qureshi S.A., Leung S., Kerr I.M., Stark G.R., Darnell J.E. Function of Stat2 protein in transcriptional activation by alpha interferon. Mol. Cell. Biol. 1996, 16:288-293.
42. Muller M., Laxton C., Briscoe J., Schindler C., Improta T., Darnell J.E., et al. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways. EMBO J. 1993, 12:4221-4228.
43. Levy D.E., Kessler D.S., Pine R., Darnell J.E. Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro. Genes Dev. 1989, 3:1362-1371.
44. Kessler D.S., Veals S.A., Fu X.Y., Levy D.E. Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes Dev. 1990, 4:1753-1765.
45. Veals S.A., Schindler C., Leonard D., Fu X.Y., Aebersold R., Darnell J.E., et al. Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol. Cell. Biol. 1992, 12:3315-3324.
46. Lau J.F., Parisien J.P., Horvath C.M. Interferon regulatory factor subcellular localization is determined by a bipartite nuclear localization signal in the DNA-binding domain and interaction with cytoplasmic retention factors. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:7278-7283.
47. Testoni B., Vollenkle C., Guerrieri F., Gerbal-Chaloin S., Blandino G., Levrero M. Chromatin dynamics of gene activation and repression in response to interferon alpha (IFN(alpha)) reveal new roles for phosphorylated and unphosphorylated forms of the transcription factor STAT2. J. Biol. Chem. 2011, 286:20217-20227.
48. Cheon H., Stark G.R. Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9373-9378.
49. Lou Y.J., Pan X.R., Jia P.M., Li D., Xiao S., Zhang Z.L., et al. IRF-9/STAT2 [corrected] functional interaction drives retinoic acid-induced gene G expression independently of STAT1. Cancer Res. 2009, 69:3673-3680.
50. Haan S., Kortylewski M., Behrmann I., Muller-Esterl W., Heinrich P.C., Schaper F. Cytoplasmic STAT proteins associate prior to activation. Biochem. J 2000, 345(Part 3):417-421.
51. Stancato L.F., David M., Carter-Su C., Larner A.C., Pratt W.B. Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation. J. Biol. Chem. 1996, 271:4134-4137.
52. Melen K., Fagerlund R., Franke J., Kohler M., Kinnunen L., Julkunen I. Importin alpha nuclear localization signal binding sites for STAT1, STAT2, and influenza A virus nucleoprotein. J. Biol. Chem. 2003, 278:28193-28200.
53. Cheon H., Holvey-Bates E.G., Schoggins J.W., Forster S., Hertzog P., Imanaka N., et al. IFNbeta-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage. EMBO J. 2013, 32:2751-2763.
54. Kolosenko I., Fryknas M., Forsberg S., Johnsson P., Cheon H., Holvey-Bates E.G., et al. Cell crowding induces interferon regulatory factor 9, which confers resistance to chemotherapeutic drugs. Int. J. Cancer 2015, 136:E51-61.
55. Improta T., Schindler C., Horvath C.M., Kerr I.M., Stark G.R., Darnell J.E. Transcription factor ISGF-3 formation requires phosphorylated Stat91 protein, but Stat113 protein is phosphorylated independently of Stat91 protein. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:4776-4780.
56. Leung S., Qureshi S.A., Kerr I.M., Darnell J.E. Stark GR. Role of STAT2 in the alpha interferon signaling pathway. Mol. Cell. Biol. 1995, 15:1312-1317.
57. Bluyssen H.A., Levy D.E. Stat2 is a transcriptional activator that requires sequence-specific contacts provided by stat1 and p48 for stable interaction with DNA. J. Biol. Chem. 1997, 272:4600-4605.
58. Kraus T.A., Lau J.F., Parisien J.P., Horvath C.M. A hybrid IRF9-STAT2 protein recapitulates interferon-stimulated gene expression and antiviral response. J. Biol. Chem. 2003, 278:13033-13038.
59. Poat B., Hazari S., Chandra P.K., Gunduz F., Alvarez X., Balart L.A., et al. Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication. Virol. J. 2010, 7:265.
60. Fink K., Grandvaux N. STAT2 and IRF9: beyond ISGF3. JAKSTAT 2013, 2:e27521.
61. Steen H.C., Gamero A.M. The role of signal transducer and activator of transcription-2 in the interferon response. J. Interferon Cytokine Res. 2012, 32:103-110.
62. Steen H.C., Gamero A.M. STAT2 phosphorylation and signaling. JAKSTAT 2013, 2:e25790.
63. Bluyssen A.R., Durbin J.E., Levy D.E. ISGF3 gamma p48, a specificity switch for interferon activated transcription factors. Cytokine Growth Factor Rev. 1996, 7:11-17.
64. Wesoly J., Szweykowska-Kulinska Z., Bluyssen H.A. STAT activation and differential complex formation dictate selectivity of interferon responses. Acta Biochim. Pol. 2007, 54:27-38.
65. Sarkis P.T., Ying S., Xu R., Yu X.F. STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-alpha. J. Immunol. 2006, 177:4530-4540.
66. George C.X., Das S., Samuel C.E. Organization of the mouse RNA-specific adenosine deaminase Adar1 gene 5'-region and demonstration of STAT1-independent, STAT2-dependent transcriptional activation by interferon. Virology 2008, 380:338-343.
67. Fink K., Martin L., Mukawera E., Chartier S., De Deken X., Brochiero E., et al. IFNbeta/TNFalpha synergism induces a non-canonical STAT2/IRF9-dependent pathway triggering a novel DUOX2 NADPH oxidase-mediated airway antiviral response. Cell Res. 2013, 23:673-690.
68. Hahm B., Trifilo M.J., Zuniga E.I., Oldstone M.B. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 2005, 22:247-257.
69. Ousman S.S., Wang J., Campbell I.L. Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection. J. Virol. 2005, 79:7514-7527.
70. Zimmerer J.M., Lesinski G.B. Radmacher MD, Ruppert A, Carson WE.;1;, 3rd. STAT1-dependent and STAT1-independent gene expression in murine immune cells following stimulation with interferon-alpha. Cancer Immunol. Immunother. 2007, 56:1845-1852.
71. Perry S.T., Buck M.D., Lada S.M., Schindler C., Shresta S. STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. PLoS Pathog. 2011, 7:e1001297.
72. Bowick G.C., Airo A.M., Bente D.A. Expression of interferon-induced antiviral genes is delayed in a STAT1 knockout mouse model of Crimean-Congo hemorrhagic fever. Virol. J. 2012, 9:122.
73. Didcock L., Young D.F., Goodbourn S., Randall R.E. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 1999, 73:9928-9933.
74. Ramachandran A., Horvath C.M. Paramyxovirus disruption of interferon signal transduction: sTATus report. J. Interferon Cytokine Res. 2009, 29:531-537.
75. Veals S.A., Santa Maria T., Levy D.E. Two domains of ISGF3 gamma that mediate protein-DNA and protein-protein interactions during transcription factor assembly contribute to DNA-binding specificity. Mol. Cell. Biol. 1993, 13:196-206.
76. Hartman S.E., Bertone P., Nath A.K., Royce T.E., Gerstein M., Weissman S., et al. Global changes in STAT target selection and transcription regulation upon interferon treatments. Genes Dev. 2005, 19:2953-2968.
77. Schmid S., Mordstein M., Kochs G., Garcia-Sastre A., Tenoever B.R. Transcription factor redundancy ensures induction of the antiviral state. J. Biol. Chem. 2010, 285:42013-42022.
78. Hofer M.J., Li W., Manders P., Terry R., Lim S.L., King N.J., et al. Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus. J. Virol. 2012, 86:6932-6946.
79. Li W., Hofer M.J., Jung S.R., Lim S.L., Campbell I.L. IRF7-dependent type I interferon production induces lethal immune-mediated disease in STAT1 knockout mice infected with lymphocytic choriomeningitis virus. J. Virol. 2014, 88:7578-7588.
80. Fenner J.E., Starr R., Cornish A.L., Zhang J.G., Metcalf D., Schreiber R.D., et al. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat. Immunol. 2006, 7:33-39.
81. Kramer O.H., Knauer S.K., Greiner G., Jandt E., Reichardt S., Guhrs K.H., et al. A phosphorylation-acetylation switch regulates STAT1 signaling. Genes Dev. 2009, 23:223-235.
82. Wieczorek M., Ginter T., Brand P., Heinzel T., Kramer O.H. Acetylation modulates the STAT signaling code. Cytokine Growth Factor Rev. 2012, 23:293-305.
83. Maarifi G., Maroui M.A., Dutrieux J., Dianoux L., Nisole S., Chelbi-Alix M.K. Small ubiquitin-like modifier alters IFN response. J. Immunol. 2015, 195:2312-2324.
84. Zimnik S., Gaestel M., Niedenthal R. Mutually exclusive STAT1 modifications identified by Ubc9/substrate dimerization-dependent SUMOylation. Nucleic Acids Res. 2009, 37:e30.
85. Xu W., Edwards M.R., Borek D.M., Feagins A.R., Mittal A., Alinger J.B., et al. Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1. Cell Host Microbe 2014, 16:187-200.
86. Garcin D., Marq J.B., Strahle L., le Mercier P., Kolakofsky D. All four Sendai Virus C proteins bind Stat1, but only the larger forms also induce its mono-ubiquitination and degradation. Virology 2002, 295:256-265.
87. Yokosawa N., Yokota S., Kubota T., Fujii N. C-terminal region of STAT-1alpha is not necessary for its ubiquitination and degradation caused by mumps virus V protein. J. Virol. 2002, 76:12683-12690.
88. Bluyssen H. STAT2-directed pathogen responses. Oncotarget 2015, 6:28525-28526.